Dr. Ana Andreazza is a Professor in the Departments of Pharmacology & Toxicology and Psychiatry at the University of Toronto, Tier II Canada Research Chair in Molecular Pharmacology of Mood Disorders, and the Thomas C. Zachos Chair in Mitochondrial Research. Her research focuses on mitochondrial bioenergetics across mood disorders, organ transplantation, and regenerative medicine. She has identified mitochondrial gene dysfunctions in bipolar disorder and pioneered the use of human brain organoids to study bioenergetic mechanisms underlying psychiatric illness and treatment response. Recently awarded $24M through the NFRF Transformation program, her collaborative translational research aims to advance mitochondrial transplantation therapeutics and improve clinical outcomes and regenerative medicine.